Nicholas Butowski

Cancer Center Support Grant

National Cancer Institute · P30

Project lead · $2.1M · University of California, San Francisco

Advancing Treatment and Understanding of Immunotherapy in Glioblastoma

National Cancer Institute · U19

Contact PI · $5M · University of California, San Francisco

A Phase I Study of CED of Liposomal-Irinotecan Using Imaging in High Grade Glioma

National Cancer Institute · R21

Contact PI · $651.1K · University of California, San Francisco

A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.

Principal investigator · Not yet recruiting · Phase 1

Nicholas Butowski

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Principal investigator · Recruiting · Phase 1, Phase 2

University of California, San Francisco

RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

Principal investigator · Terminated · Phase 1

Nicholas Butowski

VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM

Principal investigator · Terminated · Phase 3

DelMar Pharmaceuticals, Inc.